Related references
Note: Only part of the references are listed.Dengue infection: neurological manifestations and cerebrospinal fluid (CSF) analysis
C. N. Soares et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
EEG in dengue virus infection with neurological manifestations: A clinical and CT/MRI correlation
J. Kalita et al.
CLINICAL NEUROPHYSIOLOGY (2006)
Molecular and phenotypic analysis of a working seed lot of yellow fever virus 17DD vaccine strain produced from the secondary seed lot 102/84 with an additional passage in chicken embryos
Renato S. Marchevsky et al.
BIOLOGICALS (2006)
Protection of rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination
Wellington Sun et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax™-DEN2) vaccine:: Phase I clinical trial for safety and immunogenicity
Farshad Guirakhoo et al.
HUMAN VACCINES (2006)
Attenuation and immunogenicity of recombinant yellow fever 17D-dengue type 2 virus for rhesus monkeys
R Galler et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2005)
An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model
JR Putnak et al.
VACCINE (2005)
Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys
JE Blaney et al.
JOURNAL OF VIROLOGY (2005)
Dengue virus infections: comparison of methods for diagnosing the acute disease
CD Poersch et al.
JOURNAL OF CLINICAL VIROLOGY (2005)
Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children
A Sabchareon et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle?
DJ Gubler
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2004)
Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine
R Edelman et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2003)
Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys
RS Marchevsky et al.
VIROLOGY (2003)
Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay
HG Bae et al.
JOURNAL OF VIROLOGICAL METHODS (2003)
Sensitivity and reproducibility of HCV quantitation in chimpanzee sera using TaqMan real-time PCR assay
M Puig et al.
JOURNAL OF VIROLOGICAL METHODS (2002)
Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, Dengue virus, and Yellow fever virus by real-time reverse transcription-PCR
C Drosten et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: Genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates
F Guirakhoo et al.
VIROLOGY (2002)
Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: Role of serotype concentration, ratio, and multiple doses
A Sabchareon et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3′-untranslated region
AP Durbin et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2001)
Development of a fluorogenic RT-PCR system for quantitative identification of dengue virus serotypes 1-4 using conserved and serotype-specific 3′ noncoding sequences
HSH Houng et al.
JOURNAL OF VIROLOGICAL METHODS (2001)
Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers
N Kanesa-thasan et al.
VACCINE (2001)
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates
F Guirakhoo et al.
JOURNAL OF VIROLOGY (2000)
Neurological manifestations of dengue infection
T Solomon et al.
LANCET (2000)
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity
DW Vaughn et al.
JOURNAL OF INFECTIOUS DISEASES (2000)